1. Home
  2. DHX vs ELDN Comparison

DHX vs ELDN Comparison

Compare DHX & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHX
  • ELDN
  • Stock Information
  • Founded
  • DHX 1991
  • ELDN 2004
  • Country
  • DHX United States
  • ELDN United States
  • Employees
  • DHX N/A
  • ELDN N/A
  • Industry
  • DHX Business Services
  • ELDN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DHX Consumer Discretionary
  • ELDN Health Care
  • Exchange
  • DHX Nasdaq
  • ELDN Nasdaq
  • Market Cap
  • DHX 143.1M
  • ELDN 164.1M
  • IPO Year
  • DHX 2007
  • ELDN N/A
  • Fundamental
  • Price
  • DHX $2.10
  • ELDN $3.49
  • Analyst Decision
  • DHX Strong Buy
  • ELDN Strong Buy
  • Analyst Count
  • DHX 2
  • ELDN 2
  • Target Price
  • DHX $5.25
  • ELDN $12.50
  • AVG Volume (30 Days)
  • DHX 436.0K
  • ELDN 1.4M
  • Earning Date
  • DHX 11-10-2025
  • ELDN 11-11-2025
  • Dividend Yield
  • DHX N/A
  • ELDN N/A
  • EPS Growth
  • DHX N/A
  • ELDN N/A
  • EPS
  • DHX N/A
  • ELDN 0.21
  • Revenue
  • DHX $134,396,000.00
  • ELDN N/A
  • Revenue This Year
  • DHX N/A
  • ELDN N/A
  • Revenue Next Year
  • DHX N/A
  • ELDN N/A
  • P/E Ratio
  • DHX N/A
  • ELDN $16.55
  • Revenue Growth
  • DHX N/A
  • ELDN N/A
  • 52 Week Low
  • DHX $1.21
  • ELDN $2.32
  • 52 Week High
  • DHX $3.34
  • ELDN $5.54
  • Technical
  • Relative Strength Index (RSI)
  • DHX 32.77
  • ELDN 68.48
  • Support Level
  • DHX $2.02
  • ELDN $3.18
  • Resistance Level
  • DHX $2.11
  • ELDN $3.76
  • Average True Range (ATR)
  • DHX 0.12
  • ELDN 0.28
  • MACD
  • DHX -0.01
  • ELDN 0.07
  • Stochastic Oscillator
  • DHX 21.87
  • ELDN 78.40

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: